Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-08-12 Sale |
2021-08-12 9:33 pm |
TherapeuticsMD Inc. | TXMD | DArecca James Chief Financial Officer |
93,337 | $0.87 | $81,203 | 558,163 (Direct) |
View |
| 2020-05-08 Sale |
2020-05-11 9:50 pm |
Allergan plc | AGN | DArecca James SVP Chief Accounting Officer |
3,511 | $0 | $0 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-08-06 Option Award |
2024-08-07 4:04 pm |
N/A N/A |
Prestige Consumer Healthcare Inc. | PBH | DArecca James Director |
2,202 | $0 | 4,497 (Direct) |
View |
| 2024-05-17 Option Award |
2024-05-21 5:41 pm |
N/A 2031-05-17 |
HAEMONETICS CORP | HAE | DArecca James EVP, Chief Financial Officer |
14,195 | $0 | 27,102 (Direct) |
View |
| 2024-05-15 Tax Withholding |
2024-05-17 4:52 pm |
N/A N/A |
HAEMONETICS CORP | HAE | DArecca James EVP, Chief Financial Officer |
412 | $96.49 | 12,907 (Direct) |
View |
| 2024-05-16 Tax Withholding |
2024-05-17 4:52 pm |
N/A N/A |
HAEMONETICS CORP | HAE | DArecca James EVP, Chief Financial Officer |
351 | $94.8 | 12,907 (Direct) |
View |
| 2024-05-02 Tax Withholding |
2024-05-06 4:19 pm |
N/A N/A |
HAEMONETICS CORP | HAE | DArecca James EVP, Chief Financial Officer |
432 | $93.33 | 13,670 (Direct) |
View |
| 2023-08-01 Option Award |
2023-08-03 2:01 pm |
N/A N/A |
Prestige Consumer Healthcare Inc. | PBH | DArecca James Director |
2,295 | $0 | 2,295 (Direct) |
View |
| 2023-05-16 Tax Withholding |
2023-05-17 4:26 pm |
N/A N/A |
HAEMONETICS CORP | HAE | DArecca James EVP, Chief Financial Officer |
349 | $89.21 | 23,604 (Direct) |
View |
| 2023-05-15 Option Award |
2023-05-17 4:26 pm |
N/A 2030-05-15 |
HAEMONETICS CORP | HAE | DArecca James EVP, Chief Financial Officer |
13,707 | $0 | 23,604 (Direct) |
View |
| 2023-05-02 Tax Withholding |
2023-05-04 4:27 pm |
N/A N/A |
HAEMONETICS CORP | HAE | DArecca James EVP, Chief Financial Officer |
430 | $81.66 | 10,246 (Direct) |
View |
| 2022-05-16 Option Award |
2022-05-18 4:34 pm |
N/A 2029-05-16 |
HAEMONETICS CORP | HAE | DArecca James EVP, Chief Financial Officer |
15,937 | $0 | 21,839 (Direct) |
View |
| 2022-05-02 Option Award |
2022-05-04 4:41 pm |
N/A 2029-05-02 |
HAEMONETICS CORP | HAE | DArecca James EVP, Chief Financial Officer |
19,730 | $0 | 19,730 (Direct) |
View |
| 2021-08-10 Exercise |
2021-08-12 9:33 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | DArecca James Chief Financial Officer |
217,167 | $0 | 558,163 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-02 5:45 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | DArecca James CFO |
520,000 | $0 | 520,000 (Direct) |
View |
| 2020-06-18 Option Award(A) |
2020-08-07 9:16 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | DArecca James Chief Financial Officer |
803,000 | $0 | 803,000 (Direct) |
View |
| 2020-06-18 Option Award |
2020-06-19 5:07 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | DArecca James Chief Financial Officer |
803,000 | $0 | 803,000 (Direct) |
View |